---
id: aasld-hepatitis-b-2025
title: "AASLD/IDSA Practice Guideline on Treatment of Chronic Hepatitis B"
short_title: "AASLD Hepatitis B 2025"

organization: American Association for the Study of Liver Diseases
collaborators:
  - Infectious Diseases Society of America
country: US
url: https://www.aasld.org/practice-guidelines/chronic-hepatitis-b
doi: 10.1097/HEP.0000000000001549
pmid: 41186418
open_access: false

specialty: gastroenterology
guideline_type: clinical-practice
evidence_system: GRADE
conditions:
  - chronic hepatitis B
  - HBV infection
  - hepatitis B virus
tags:
  - antiviral therapy
  - entecavir
  - tenofovir
  - HBsAg
  - HCC surveillance
  - mother-to-child transmission

publication_date: 2025-11-04
previous_version_date: 2018-04-01
status: current
supersedes: aasld-hepatitis-b-2018
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-21
---

## Scope

Evidence-based guideline for prevention, surveillance, and treatment of chronic hepatitis B infection including maternal-to-infant transmission prevention, HCC surveillance, and antiviral therapy indications.

## Notes

Joint AASLD/IDSA guideline developed using PICO framework. Addresses 6 PICO questions covering prevention, liver cancer surveillance, and treatment.
